Aerosolized Micropolyspora faeni antigen as a cause of pulmonary dysfunction in ponies with recurrent airway

F J Derksen1, N E Robinson, J S Scott

  • 1Pulmonary Laboratory, College of Veterinary Medicine, Michigan State University, East Lansing 48824.

Insights

Micropolyspora faeni antigen exposure exacerbated airway inflammation and altered pulmonary function in ponies with recurrent airway obstruction. This suggests M. faeni may be an important factor in equine chronic obstructive pulmonary disease.

Area of Science:

  • Equine respiratory medicine
  • Immunology
  • Pulmonary physiology

Background:

  • Recurrent airway obstruction (RAO) is a common respiratory condition in horses.
  • Micropolyspora faeni is a known environmental antigen implicated in respiratory diseases.

Purpose of the Study:

  • To investigate the effects of aerosolized Micropolyspora faeni antigen on ponies with and without recurrent airway obstruction.
  • To determine the role of M. faeni in the pathogenesis of equine chronic obstructive pulmonary disease (COPD).

Main Methods:

  • Bronchoalveolar lavage (BAL) and pulmonary function tests were performed on principal (RAO) and control ponies.
  • Ponies received aerosolized saline or M. faeni antigen during disease remission.
  • BAL fluid and pulmonary mechanics were assessed 5 hours post-administration.

Main Results:

  • M. faeni antigen increased white blood cell count, neutrophils, and albumin in BAL fluid of both groups.
  • Macrophage counts decreased, and mast cell numbers decreased in principal ponies.
  • Pulmonary function changes (increased respiratory frequency, minute ventilation, pulmonary resistance; decreased arterial oxygen tension) were observed only in principal ponies.

Conclusions:

  • Aerosolized M. faeni antigen induces airway inflammation and pulmonary dysfunction specifically in ponies with RAO.
  • Neutrophils alone may not cause pulmonary dysfunction in RAO.
  • M. faeni is a potential etiologic agent in equine COPD.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...